NCT04535908

Hypofractionated Radiotherapy in Prostate Cancer Patients Aged 75 Years or Older.

Clinical Study to Evaluate Hypofractionated Radiotherapy in Prostate Cancer Patients Aged 75 Years or Older.

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 23 (actual)
• Sponsor: Medical University of Graz · Academic / Other
• Sex: Male
• Age: 75 Years
• Healthy volunteers: Not accepted

Summary

The majority of all new prostate cancer cases are diagnosed in men aged \> 70 years, with the highest incidence in men aged \> 90 years. Management options for localized prostate cancer include active surveillance in patients with low-risk disease, radical prostatectomy or external beam radiation therapy. In previous studies, hypofractionated prostate cancer irradiation regimens have been shown to represent a highly effective treatment option for prostate cancer. However, patients aged 75 years or older were underrepresented in most trials resulting in the lack of a robust evidence base. The proposed study will evaluate radiation-induced toxicity as well as outcome after hypofractionated external beam radiotherapy in prostate cancer patients aged 75 years or older.

Conditions

• Prostate Cancer
• Radiotherapy Side Effect

Interventions

Type	Name	Description
RADIATION	Hypofractionated radiotherapy	Hypofractionated radiotherapy in prostate cancer patients

Timeline

• Start date: 2020-09-16
• Primary completion: 2022-05-25
• Completion: 2022-05-25
• First posted: 2020-09-02
• Last updated: 2022-10-03

Locations

1 site across 1 country: Austria